News

Lab personnel atend RCMI 2019 National Conference

This year our lab personnel had the opportunity to attend to the “RCMI 2019 National Conference”; Collaborative Solutions to Improve Minority Health & Reduce Health Disparities, from December 15-17 in Bethesda, Maryland. During this conference different basic biomedical science, behavioral science and clinical science and health services research were presented. The primary aim of this conference was to extend the reach and visibility of communities whose interest is improving health outcomes. Dr. Ednalise Santiago had the opportunity to present her research poster “Proteomic Study of Hispanics with resistance to Clopidogrel”.

December 17, 2019

Figure 1 From the left to the right; Dr. Jorge Duconge and Dr. Ednalise Santiago at the RCMI Conference, December 15-17, 2019.

From the left to the right; Dr. Jorge Duconge and Dr. Ednalise Santiago at the RCMI Conference, December 15-17, 2019.

From the left to the right; Dr. Jorge Duconge, Dr. Ednalise Santiago and Frances M. Marín at the RCMI Conference, December 15-17, 2019.

From the left to the right; Dr. Jorge Duconge, Dr. Ednalise Santiago and Frances M. Marín at the RCMI Conference, December 15-17, 2019.

From the left to the right; Dr. Bianca Torres and Dr. Jorge Duconge at the RCMI Conference, December 15-17, 2019

From the left to the right; Dr. Bianca Torres and Dr. Jorge Duconge at the RCMI Conference, December 15-17, 2019

Figure 4 From the left to the right; Dr. Kyle Melin, Dr. Bianca Torres, Dr. Jorge Duconge and Dr. Darlene Santiago at the RCMI 2019 National Conference.

From the left to the right; Dr. Kyle Melin, Dr. Bianca Torres, Dr. Jorge Duconge and Dr. Darlene Santiago at the RCMI 2019 National Conference.

Figure 5  Dr. Jorge Duconge during the oral presentation; “Genome-wide Association Study of Clopidogrel in Caribbean Hispanics” at the RCMI 2019 National Conference.

Dr. Jorge Duconge during the oral presentation; “Genome-wide Association Study of Clopidogrel in Caribbean Hispanics” at the RCMI 2019 National Conference.

Dr. Jorge Duconge during the oral presentation; “Genome-wide Association Study of Clopidogrel in Caribbean Hispanics” at the RCMI 2019 National Conference.

Dr. Jorge Duconge during the oral presentation; “Genome-wide Association Study of Clopidogrel in Caribbean Hispanics” at the RCMI 2019 National Conference.

Congratulations to Dr. Ednalise Santiago whose poster received an Honorable Mention

ednalise

Ednalise

The RCMI Center for Collaborative Research in Health Disparities (CCRHD) and the Pgx Lab congratulates Dr. Ednalise Santiago, whose poster presentation at the American Society of Human Genetics received an Honorable Mention.  Dr. Santiago’s poster at the Pharmaco-genomics Research Network (PGRN) was entitled “Quantitative Proteomic Profile of Caribbean Hispanics with High on-Treatment Platelet Reactivity (HTPR) to Clopidogrel” and it summarized preliminary data obtained in her post-doctoral project.  Congratulations to Dr. Santiago in this achievement! October 29, 2019 




 

Tags: 

Dr. Duconge attended the 5th Congress of the European Society for Pharmacogenomics and Personalized Therapy (ESPT)

Duconge

Dr. Duconge attended the 5th Congress of the European Society for Pharmacogenomics and Personalized Therapy (ESPT), “Precision Medicine and Personalized Health”, which was held in Seville, Spain, from October 16-18th, 2019. In this meeting, Dr. Duconge presented the following research projects; “Machine Learning Algorithm for Predicting Warfarin Doses in Caribbean Hispanics Using Pharmacogenetic Data” and the “Effect of Gene-Drug Interactions Linked to Clopidogrel and Cilostazol on Platelet Reactivity among Patients with Peripheral Artery Disease” in the corresponding poster sessions. Additionally, he attended meetings as a member of the RIBEF (Red Iberoamericana de Farmacogenomica as it stands in Spanish), and met with collaborators from Europe (Drs. Adrián Llerena and Munir Pirmohamed). October 29, 2019.

Poster presentation

Tags: 

Pages